Publications:
A selected list of publications:
Perez Omar D, Logg Christopher R, Hiraoka Kei, Diago Oscar, Burnett Ryan, Inagaki Akihito, Jolson Dawn, Amundson Karin, Buckley Taylor, Lohse Dan, Lin Amy, Burrascano Cindy, Ibanez Carlos, Kasahara Noriyuki, Gruber Harry E, Jolly Douglas J
Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression
Molecular Therapy,
2012; 20(9):
1689-98.
Tai C-K, Wang W, Lai Y-H, Logg CR, Parker WB, Li Y-F, Hong JS, Sorscher EJ, Chen TC, Kasahara N
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene
Cancer Gene Therapy,
2010; 17(9):
614-23.
Haga Kazunori, Tomioka Atsushi, Liao Chun-Peng, Kimura Takahiro, Matsumoto Hiroshi, Ohno Izumi, Hermann Kip, Logg Christopher R, Jiao Jing, Tanaka Motoyoshi, Hirao Yoshihiko, Wu Hong, Kruse Carol A, Roy-Burman Pradip, Kasahara Noriyuki
PTEN knockout prostate cancer as a model for experimental immunotherapy
Journal of Urology,
2009; 181(1):
354-62.
Haga K, Lemp NA, Logg CR, Nagashima J, Faure-Kumar E, Gomez GG, Kruse CA, Mendez R, Stripecke R, Kasahara N, Kasahara N, Cicciarelli JC
Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes
Transplantation Proceedings,
2006; 38(10):
3184-8.
Soifer Harris, Higo Collin, Logg Christopher R, Jih Lily Ja-Lu, Shichinohe Toshiaki, Harboe-Schmidt Erik, Mitani Kohnosuke, Kasahara Noriyuki
A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism
Molecular Therapy,
2002; 5(5 Pt 1):
599-608.